Kathleen Martin, PhD
VP Program Management & Strategy
Kathleen leads clinical program teams that develop new treatments to enable people to live longer and healthier lives. With 20 years of experience in the biotech and pharmaceutical industry, Kathleen has drug development experience extending from target discovery to late-stage clinical development, including experience with small molecule therapeutics, drug-device combinations, cell therapies and digital medicines. Prior to joining BIOAGE, Kathleen was a senior director in Calico, where she led the development of therapeutics in age-related diseases. Prior to that, as Vice President of Project and Portfolio Management in Biotie Therapies, she led cross-functional project teams, proactively identifying complex challenges and implementing risk mitigation strategies. Kathleen received her PhD in Neurobiology from Yale University and is particularly passionate about optimizing cognitive functioning through the lifespan.